January 04, 2025 02:57 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow | Punjab cop dismissed for facilitating TV interview of Larence Bishnoi while in custody | 'Not Veer Savarkar', Congress student wing demands Delhi college be named after Manmohan Singh | 'Cowardly': PM Modi condemns New Orleans terrorist attack that killed 15 | Prashant Kishor starts fast unto death over Bihar Public Service Commission prelims cancellation demand | Bangladesh court denies bail to arrested Hindu monk Chinmoy Krishna Das
Coronavirus Vaccine
Image Credit: Pixabay

AstraZeneca-Oxford and Pfizer vaccines provide over 80 pc protection against Covid variant first found in India

| @indiablooms | May 23, 2021, at 06:53 am

London/IBNS: Two doses of AstraZeneca vaccine or Pfizer vaccine can give more than 80 per cent protection from the B1.617.2 variant of coronavirus first found in India, a new study conducted by the UK government has revealed, media reports said.

The study is based on the data from Public Health England (PHE), media reports informed.

It also found that the two doses provide 87 per cent protection from B.117 variant first found in Kent region of England and also considered highly transmissible, the reports stated.

The latest PHE data have shown that the infection from B1.617.2 have risen by 2,111 over the past week and now stand at 3,424 cases across the country.

AstraZeneca vaccine is manufactured in India by Serum Institute of India under the name of Covishield.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.